Where Do We Stand with Aspirin for the Prevention of Colorectal Cancer? the USPSTF Recommendations

Gastroenterology

Volumn 150, Issue 1, 2016, Pages 14-18

  Chan, Andrew T ^a,b   Ladabaum, Uri ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CLINICAL PRACTICE; COLONOSCOPY; COLORECTAL CANCER; DRUG EFFICACY; DRUG UTILIZATION; FOLLOW UP; HUMAN; LONG TERM CARE; LOW RISK POPULATION; MEDICATION COMPLIANCE; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; SMOKING; AGED; CHEMOPROPHYLAXIS; COLORECTAL NEOPLASMS; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; MALE; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STANDARDS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

AGED; ASPIRIN; CHEMOPREVENTION; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE MEDICINE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84952660923     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.11.018     Document Type: Editorial

References (30)

1. U.S. Preventive Services Task Force. Draft recommendation statement: aspirin to prevent cardiovascular disease and cancer. September 2015. Available from: www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/aspirin-to-prevent-cardiovascular-disease-and-cancer. Accessed November 19, 2015.
2. M.W. Drazer, D. Huo, and S.E. Eggener National prostate cancer screening rates after the 2012 us preventive services task force recommendation discouraging prostate-specific antigen-based screening J Clin Oncol 33 2015 2416 2423
3. J. Chubak, A. Kamineni, D.S. Buist, and et al. Aspirin use for the prevention of colorectal cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 133. AHRQ Publication No. 15-05228-EF-1 2015 Agency for Healthcare Research and Quality Rockville, MD
4. A.T. Chan, N. Arber, J. Burn, and et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview Cancer Prev Res (Phila) 5 2012 164 178
5. T. Sturmer, R.J. Glynn, I.M. Lee, and et al. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study Ann Intern Med 128 1998 713 720
6. N.R. Cook, I.M. Lee, J.M. Gaziano, and et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial JAMA 294 2005 47 55
7. J. Burn, D.T. Bishop, J.P. Mecklin, and et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome N Engl J Med 359 2008 2567 2578
8. B.F. Cole, R.F. Logan, S. Halabi, and et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials J Natl Cancer Inst 101 2009 256 266
9. H. Ishikawa, M. Mutoh, S. Suzuki, and et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial Gut 63 2014 1755 1759
10. H.C. Pommergaard, J. Burcharth, J. Rosenberg, and et al. Aspirin, calcitriol, and calcium do not prevent adenoma recurrence in a randomized controlled trial Gastroenterology 150 2016 114 122
11. A.T. Chan, E.L. Giovannucci, E.S. Schernhammer, and et al. A prospective study of aspirin use and the risk for colorectal adenoma Ann Intern Med 140 2004 157 166
12. A.T. Chan, S. Ogino, and C.S. Fuchs Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N Engl J Med 356 2007 2131 2142
13. N.R. Cook, I.M. Lee, S.M. Zhang, and et al. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial Ann Intern Med 159 2013 77 85
14. J. Burn, A.M. Gerdes, F. Macrae, and et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Lancet 378 2011 2081 2087
15. P.M. Rothwell, M. Wilson, C.E. Elwin, and et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Lancet 376 2010 1741 1750
16. J.M. Guirguis-Blake, C.V. Evans, C.A. Senger, and et al. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 131 2015 Agency for Healthcare Research and Quality Rockville, MD
17. E.P. Whitlock, S.B. Williams, B.U. Burda, and et al. Aspirin use in adults: cancer, all-cause mortality, and harms. A systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 132. AHRQ Publication No. 13-05193-EF-1 September 2015 Agency for Healthcare Research and Quality Rockville, MD
18. S.P. Dehmer, M.V. Maciosek, and T.J. Flottemesch Aspirin use to prevent cardiovascular disease and cancer: a decision analysis. AHRQ Publication No. 15-05229-EF-1 2015 Agency for Healthcare Research and Quality Rockville, MD
19. Draft recommendation statement: colorectal cancer: screening. U.S. Preventive Services Task Force. October 2015. Available from: www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement38/colorectal-cancer-screening2. Accessed November 19, 2015.
20. P. Hewitson, P. Glasziou, E. Watson, and et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update Am J Gastroenterol 103 2008 1541 1549
21. A. Shaukat, S.J. Mongin, M.S. Geisser, and et al. Long-term mortality after screening for colorectal cancer N Engl J Med 369 2013 1106 1114
22. J.S. Mandel, T.R. Church, J.H. Bond, and et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 2000 1603 1607
23. B.J. Elmunzer, R.A. Hayward, P.S. Schoenfeld, and et al. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials PLoS Med 9 2012 e1001352
24. S.J. Winawer, A.G. Zauber, M.N. Ho, and et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1993 1977 1981
25. A.G. Zauber, S.J. Winawer, M.J. O'Brien, and et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths N Engl J Med 366 2012 687 696
26. R. Nishihara, K. Wu, P. Lochhead, and et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy N Engl J Med 369 2013 1095 1105
27. U. Ladabaum, C.L. Chopra, G. Huang, and et al. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis Ann Intern Med 135 2001 769 781
28. J. Cuzick, M.A. Thorat, C. Bosetti, and et al. Estimates of benefits and harms of prophylactic use of aspirin in the general population Ann Oncol 26 2015 47 57
29. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial Contemp Clin Trials 36 2013 555 564
30. M.K. Gala, and A.T. Chan Molecular pathways: aspirin and Wnt signaling- A molecularly targeted approach to cancer prevention and treatment Clin Cancer Res 21 2015 1543 1548